{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:16:07Z","timestamp":1783113367845,"version":"3.54.6"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013061","name":"Jilin Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20220402083GH"],"award-info":[{"award-number":["20220402083GH"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014862","name":"Yangzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["YZ2025149"],"award-info":[{"award-number":["YZ2025149"]}],"id":[{"id":"10.13039\/501100014862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cellsig.2026.112570","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:37:05Z","timestamp":1777617425000},"page":"112570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CLDN6 inhibits breast cancer growth by inducing autophagic cell death through SOX4 m6A modification"],"prefix":"10.1016","volume":"145","author":[{"given":"Qiu","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huinan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengshi","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112570_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110647","article-title":"A small-sized imidazole-derived ligand binds to the KRAS promoter G-quadruplex and inhibits cancer growth with enhanced immunomodulation","volume":"301","author":"Wang","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112570_bb0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.annonc.2020.11.011","article-title":"Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1","volume":"32","author":"Andr\u00e9","year":"2021","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112570_bb0020","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor-positive advanced breast Cancer","volume":"388","author":"Turner","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0025","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1038\/s41467-025-59210-6","article-title":"Capivasertib plus fulvestrant in patients with HR-positive\/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort","volume":"16","author":"Hu","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112570_bb0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa2511218","article-title":"Palbociclib for hormone-receptor-positive, HER2-positive advanced breast Cancer","volume":"394","author":"Metzger","year":"2026","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112570_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105572","article-title":"Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort a and B of SOLTI-1303-PATRICIA trial","volume":"10","author":"Pascual","year":"2025","journal-title":"ESMO Open."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112570_bb0040","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa2508668","article-title":"Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer","volume":"394","author":"Tolaney","year":"2026","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112570_bb0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa2406070","article-title":"Survival with trastuzumab emtansine in residual HER2-positive breast Cancer","volume":"392","author":"Geyer","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-024-01649-z","article-title":"Current and future immunotherapy for breast cancer","volume":"17","author":"Heater","year":"2024","journal-title":"J Hematol OncolJ Hematol Oncol."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112570_bb0055","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with pembrolizumab in early-stage triple-negative breast Cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2026.112570_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104351","article-title":"Recent strategies to overcome breast cancer resistance","volume":"197","author":"Khan","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cellsig.2026.112570_bb0065","article-title":"Drug resistance in breast cancer: mechanisms and strategies for management","volume":"83","author":"Wu","year":"2025","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother."},{"key":"10.1016\/j.cellsig.2026.112570_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102434","article-title":"Rethinking breast cancer follow-up based on individual risk and recurrence management","volume":"109","author":"De Rose","year":"2022","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112570_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41580-022-00542-2","article-title":"The mechanisms and roles of selective autophagy in mammals","volume":"24","author":"Vargas","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112570_bb0080","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.devcel.2021.02.010","article-title":"Autophagy and organelle homeostasis in cancer","volume":"56","author":"Miller","year":"2021","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112570_bb0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cac2.12417","article-title":"Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer","volume":"43","author":"Guo","year":"2023","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0095","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/s41467-023-38401-z","article-title":"Redefining the role of AMPK in autophagy and the energy stress response","volume":"14","author":"Park","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12943-024-02138-0","article-title":"Chaperone-mediated autophagy modulates snail protein stability: implications for breast cancer metastasis","volume":"23","author":"Ryu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112570_bb0105","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.7150\/ijbs.127562","article-title":"Triptonide-mediated PTGS2 inhibition induces autophagic cell death to suppress the progression of triple-negative breast Cancer and epithelial ovarian Cancer","volume":"22","author":"Gong","year":"2026","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112570_bb0110","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/carcin\/bgg129","article-title":"Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays","volume":"24","author":"Quan","year":"2003","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s11658-024-00629-y","article-title":"CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation","volume":"29","author":"Jin","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0120","first-page":"354","article-title":"Estrogen receptor \u03b2 inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy","volume":"38","author":"Song","year":"2019","journal-title":"J Exp Clin Cancer Res CR."},{"issue":"Pt 1","key":"10.1016\/j.cellsig.2026.112570_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2019.08.027","article-title":"SOX4: the unappreciated oncogene","volume":"67","author":"Moreno","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112570_bb0130","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1158\/0008-5472.CAN-12-1045","article-title":"SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression","volume":"72","author":"Zhang","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ccell.2020.12.001","article-title":"Integrin \u03b1v\u03b26-TGF\u03b2-SOX4 pathway drives immune evasion in triple-negative breast Cancer","volume":"39","author":"Bagati","year":"2021","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112570_bb0140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41419-021-03576-0","article-title":"miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4\/PI3K-AKT axis and predicts poor outcome","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0145","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12964-023-01360-5","article-title":"New insights into the regulation of METTL3 and its role in tumors","volume":"21","author":"Jin","year":"2023","journal-title":"Cell Commun Signal CCS."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112570_bb0150","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/BST20230574","article-title":"RNA m6A modification, signals for degradation or stabilisation?","volume":"52","author":"Wei","year":"2024","journal-title":"Biochem. Soc. Trans."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112570_bb0155","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jgg.2024.12.020","article-title":"Vitamin D receptor regulates methyltransferase like 14 to mitigate colitis-associated colorectal cancer","volume":"52","author":"Wang","year":"2025","journal-title":"J Genet Genomics Yi Chuan Xue Bao."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0165","first-page":"307","article-title":"METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer","volume":"43","author":"Bai","year":"2024","journal-title":"J Exp Clin Cancer Res CR."},{"issue":"36","key":"10.1016\/j.cellsig.2026.112570_bb0170","first-page":"157","article-title":"CLDN6 promotes chemoresistance through GSTP1 in human breast cancer","volume":"7","author":"Yang","year":"2017","journal-title":"J Exp Clin Cancer Res CR."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0175","first-page":"120","article-title":"DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac","volume":"35","author":"Liu","year":"2016","journal-title":"J Exp Clin Cancer Res CR."},{"key":"10.1016\/j.cellsig.2026.112570_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110393","article-title":"CLDN6 inhibits breast cancer cell malignant behavior by suppressing ERK signaling","volume":"97","author":"Lu","year":"2022","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0185","first-page":"68","article-title":"CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy","volume":"42","author":"Dong","year":"2023","journal-title":"J Exp Clin Cancer Res CR."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112570_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12612","article-title":"ER\u03b1 is required for suppressing OCT4-induced proliferation of breast cancer cells via DNMT1\/ISL1\/ERK axis","volume":"52","author":"Jin","year":"2019","journal-title":"Cell Prolif."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112570_bb0195","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/cas.16120","article-title":"FoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated m6A modification of SMC4","volume":"115","author":"Tan","year":"2024","journal-title":"Cancer Sci."},{"issue":"520","key":"10.1016\/j.cellsig.2026.112570_bb0200","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.canlet.2021.07.041","article-title":"Isorhapontigenin (ISO) inhibits EMT through FOXO3A\/METTL14\/VIMENTIN pathway in bladder cancer cells","volume":"1","author":"Zhang","year":"2021","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112570_bb0205","article-title":"m6A methyltransferase METTL14-mediated upregulation of cytidine deaminase promoting gemcitabine resistance in pancreatic Cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112570_bb0210","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/ni1464","article-title":"PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit","volume":"8","author":"Tanaka","year":"2007","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112570_bb0215","article-title":"PDLIM2: Signaling pathways and functions in cancer suppression and host immunity","volume":"1876","author":"Guo","year":"2021","journal-title":"Biochim Biophys Acta BBA - Rev Cancer."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112570_bb0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.annonc.2024.10.824","article-title":"Estrogens and breast cancer","volume":"36","author":"Kim","year":"2025","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112570_bb0225","doi-asserted-by":"crossref","first-page":"112688","DOI":"10.1016\/j.isci.2025.112688","article-title":"Claudin-6 mediates an embryonic stem cell-driven antitumor response against breast cancer","volume":"28","author":"Correia","year":"2025","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112570_bb0230","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","article-title":"Autophagy: regulator of cell death","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112570_bb0235","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1080\/15548627.2024.2330261","article-title":"Emerging dimensions of autophagy in melanoma","volume":"20","author":"Pangilinan","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.cellsig.2026.112570_bb0240","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0245","first-page":"105","article-title":"Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response","volume":"41","author":"Ashrafizadeh","year":"2022","journal-title":"J Exp Clin Cancer Res CR."},{"key":"10.1016\/j.cellsig.2026.112570_bb0250","article-title":"Gomisin N attenuated cerebral ischemia-reperfusion injury through inhibition of autophagy by activating the PI3K\/AKT\/mTOR pathway","volume":"110","author":"Li","year":"2023","journal-title":"Phytomedicine Int J Phytother Phytopharm."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112570_bb0255","article-title":"Targeting ESM1 via SOX4 promotes the progression of infantile hemangioma through the PI3K\/AKT signaling pathway. Precis","volume":"7","author":"Li","year":"2024","journal-title":"Clin. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0260","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1574892815666200212112119","article-title":"SOX4 serves an oncogenic role in the Tumourigenesis of human breast adenocarcinoma by promoting cell proliferation, migration and inhibiting apoptosis","volume":"15","author":"Zhang","year":"2020","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"303","key":"10.1016\/j.cellsig.2026.112570_bb0265","article-title":"SOX4-mediated FBW7 transcriptional upregulation confers tamoxifen resistance in ER+ breast cancers via GATA3 downregulation","author":"Sharma","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12964-025-02058-6","article-title":"O-GlcNAcylated FTO promotes m6A modification of SOX4 to enhance MDS\/AML cell proliferation","volume":"23","author":"Gou","year":"2025","journal-title":"Cell Commun Signal CCS."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0275","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-020-01220-7","article-title":"METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112570_bb0280","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/ijms23010129","article-title":"CLDN6 suppresses c-MYC-mediated aerobic glycolysis to inhibit proliferation by TAZ in breast Cancer","volume":"23","author":"Qu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112570_bb0285","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3892\/ijo.2016.3469","article-title":"CLDN6-induced apoptosis via regulating ASK1-p38\/JNK signaling in breast cancer MCF-7 cells","volume":"48","author":"Guo","year":"2016","journal-title":"Int. J. Oncol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826002238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826002238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:20:14Z","timestamp":1783110014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826002238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":57,"alternative-id":["S0898656826002238"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112570","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CLDN6 inhibits breast cancer growth by inducing autophagic cell death through SOX4 m6A modification","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112570"}}